NewCelX

NewCelX is a pioneering biotechnology company dedicated to the discovery and development of transformative therapies for neurodegenerative and metabolic diseases. With a focus on addressing critical unmet medical needs, NewCelX is committed to advancing innovative solutions that improve patient outcomes and enhance the quality of life. Located at The Circle, Kloten, Zurich 8302, CH, NewCelX leverages cutting-edge research and development to remain at the forefront of therapeutic innovation.

The integrated platform at NewCelX combines advanced stem-cell technologies with extensive neuroscience expertise, enabling the creation of scalable, regenerative treatments. These efforts are primarily focused on targeting debilitating conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. Furthermore, the company maintains state-of-the-art research and development operations at 3 Pinhas Sapir, Ness Ziona, Center District 7403626, IL, ensuring a global approach to therapeutic development.

NewCelX is poised to make significant strides in the biotechnology sector, continually pushing the boundaries of what is possible in regenerative medicine. We invite the manager of NewCelX to take advantage of this opportunity to create a customized and exclusive company showcase and product listing on our platform, further amplifying your company's reach and impact.